In support of this hypothesis, it has been documented that some pathogens, such as herpesviruses and some bacterial species, are commonly present in AD patients [18] prompting recent clinical research to focus on the characterization of antimicrobial peptides (AMPs), as a novel frontier for the study of this pathology. This evidence concerns the gene ADSL and Alzheimer disease.